FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080495725> ?p ?o ?g. }

• W2080495725 endingPage "386" @default.
• W2080495725 startingPage "379" @default.
• W2080495725 abstract "Cyclosporine A (CsA) is efficacious in the treatment of psoriasis. Although CsA is known to inhibit T-lymphocyte proliferation in vitro, whether this is its mode of action in psoriasis is uncertain. 12-0-tetradecanoylphorbol-13-acetate (TPA) induces an inflammatory, hyperplastic response in mouse skin, with many of the biochemical and histologic aberrations that occur in psoriatic epidermis. Protein kinase C is the major cellular phorbol ester receptor, and most responses of cells to TPA are mediated by PK-C, which is directly activated by TPA. We therefore have investigated the effects of CsA on pleiotypic responses induced by TPA and whether CsA acts in vivo as a direct inhibitor of PK-C. Simultaneous application of CsA (1.7 mumol) and TPA (10 nmol) to mouse skin significantly reduced inflammatory cell infiltration and increased epidermal thickness induced by TPA treatment alone. CsA had to be applied within 30 min of TPA application in order to have a significant inhibitory effect. Optimal doses of CsA inhibited TPA-induced ODC activity, TGase activity, arachidonic acid release, and interleukin-1 beta (IL-1 beta) mRNA to the same degree (approximately 80%), despite measurement at widely different times (30 min-12 h) required to obtain maximal induction by TPA. CsA did not, however, directly inhibit activation of PK-C by TPA. These data demonstrate that CsA blocks the pleiotypic responses of mouse skin to TPA treatment involving biochemical events, inflammatory cell infiltration, and epidermal hyperplasia. The molecular site(s) of action of CsA appears to be distal to the initial activation of PK-C by TPA and clearly inhibits PK-C inducible events. Furthermore, the above data suggest that CsA may directly affect keratinocytes in vivo." @default.
• W2080495725 created "2016-06-24" @default.
• W2080495725 creator A5001866640 @default.
• W2080495725 creator A5005798011 @default.
• W2080495725 creator A5015004042 @default.
• W2080495725 creator A5032356581 @default.
• W2080495725 creator A5033617396 @default.
• W2080495725 creator A5050138804 @default.
• W2080495725 creator A5086349143 @default.
• W2080495725 creator A5088477865 @default.
• W2080495725 date "1989-09-01" @default.
• W2080495725 modified "2023-09-27" @default.
• W2080495725 title "Topical cyclosporine A inhibits the phorbol ester induced hyperplastic inflammatory response but not protein kinase C activation in mouse epidermis" @default.
• W2080495725 cites W1538990103 @default.
• W2080495725 cites W1566003869 @default.
• W2080495725 cites W1594758412 @default.
• W2080495725 cites W1650036545 @default.
• W2080495725 cites W1964056251 @default.
• W2080495725 cites W1967046459 @default.
• W2080495725 cites W1974469880 @default.
• W2080495725 cites W1977241907 @default.
• W2080495725 cites W1978472337 @default.
• W2080495725 cites W1980348189 @default.
• W2080495725 cites W2001207556 @default.
• W2080495725 cites W2001589639 @default.
• W2080495725 cites W2002522066 @default.
• W2080495725 cites W2015536820 @default.
• W2080495725 cites W2016710605 @default.
• W2080495725 cites W2018850224 @default.
• W2080495725 cites W2020574771 @default.
• W2080495725 cites W2032845650 @default.
• W2080495725 cites W2033720492 @default.
• W2080495725 cites W2042174183 @default.
• W2080495725 cites W2057802919 @default.
• W2080495725 cites W2061319253 @default.
• W2080495725 cites W2063028339 @default.
• W2080495725 cites W2065436522 @default.
• W2080495725 cites W2073102792 @default.
• W2080495725 cites W2080268027 @default.
• W2080495725 cites W2086807901 @default.
• W2080495725 cites W2088685548 @default.
• W2080495725 cites W2089173071 @default.
• W2080495725 cites W2113581200 @default.
• W2080495725 cites W2131493069 @default.
• W2080495725 cites W2140180079 @default.
• W2080495725 cites W2151137071 @default.
• W2080495725 cites W4293247451 @default.
• W2080495725 doi "https://doi.org/10.1016/0022-202x(89)90063-8" @default.
• W2080495725 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2570112" @default.
• W2080495725 hasPublicationYear "1989" @default.
• W2080495725 type Work @default.
• W2080495725 sameAs 2080495725 @default.
• W2080495725 citedByCount "25" @default.
• W2080495725 countsByYear W20804957252016 @default.
• W2080495725 countsByYear W20804957252017 @default.
• W2080495725 countsByYear W20804957252019 @default.
• W2080495725 crossrefType "journal-article" @default.
• W2080495725 hasAuthorship W2080495725A5001866640 @default.
• W2080495725 hasAuthorship W2080495725A5005798011 @default.
• W2080495725 hasAuthorship W2080495725A5015004042 @default.
• W2080495725 hasAuthorship W2080495725A5032356581 @default.
• W2080495725 hasAuthorship W2080495725A5033617396 @default.
• W2080495725 hasAuthorship W2080495725A5050138804 @default.
• W2080495725 hasAuthorship W2080495725A5086349143 @default.
• W2080495725 hasAuthorship W2080495725A5088477865 @default.
• W2080495725 hasBestOaLocation W20804957251 @default.
• W2080495725 hasConcept C150903083 @default.
• W2080495725 hasConcept C184235292 @default.
• W2080495725 hasConcept C185592680 @default.
• W2080495725 hasConcept C195794163 @default.
• W2080495725 hasConcept C202751555 @default.
• W2080495725 hasConcept C203014093 @default.
• W2080495725 hasConcept C207001950 @default.
• W2080495725 hasConcept C2776120743 @default.
• W2080495725 hasConcept C2776914184 @default.
• W2080495725 hasConcept C2777074287 @default.
• W2080495725 hasConcept C2780564577 @default.
• W2080495725 hasConcept C2909761558 @default.
• W2080495725 hasConcept C55493867 @default.
• W2080495725 hasConcept C86803240 @default.
• W2080495725 hasConcept C98274493 @default.
• W2080495725 hasConceptScore W2080495725C150903083 @default.
• W2080495725 hasConceptScore W2080495725C184235292 @default.
• W2080495725 hasConceptScore W2080495725C185592680 @default.
• W2080495725 hasConceptScore W2080495725C195794163 @default.
• W2080495725 hasConceptScore W2080495725C202751555 @default.
• W2080495725 hasConceptScore W2080495725C203014093 @default.
• W2080495725 hasConceptScore W2080495725C207001950 @default.
• W2080495725 hasConceptScore W2080495725C2776120743 @default.
• W2080495725 hasConceptScore W2080495725C2776914184 @default.
• W2080495725 hasConceptScore W2080495725C2777074287 @default.
• W2080495725 hasConceptScore W2080495725C2780564577 @default.
• W2080495725 hasConceptScore W2080495725C2909761558 @default.
• W2080495725 hasConceptScore W2080495725C55493867 @default.
• W2080495725 hasConceptScore W2080495725C86803240 @default.
• W2080495725 hasConceptScore W2080495725C98274493 @default.
• W2080495725 hasIssue "3" @default.
• W2080495725 hasLocation W20804957251 @default.

• next